Ophelia is a telehealth startup that provides medication-assisted treatment for opioid addiction through video visits, FDA-approved medication prescriptions, and ongoing support from patients' homes. The company currently operates in 15 states and accepts most major insurance plans and Medicaid, with most patients paying less than $10 a month for care.
The company's care model was built alongside world-leading addiction medicine experts and is grounded in science. Patients are connected with a dedicated care team and can access support seven days a week. Ophelia prescribes FDA-approved medications such as Suboxone as part of its treatment programme.
Ophelia is a venture-backed company operating across the healthcare, addiction treatment, and telehealth sectors. It maintains a commitment to patient privacy and works to make evidence-based opioid addiction treatment accessible from home.
